Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccine-induced SARS-CoV-2-specific T Cell Responses in Patients With Primary Immune Deficiency Disease

NCT05321407 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05321407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05321407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccine-induced SARS-CoV-2-specific T Cell Responses in Patients With Primary Immune Deficiency Disease
Lead sponsor
Duke University
Phase
Observational
Overall status
Active, not recruiting
Start date
September 30, 2021
Completion date
July 31, 2026
Enrollment
100 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

common variable immunodeficiency, cvid, primary antibody deficiencies, primary immune deficiency, secondary hypogammaglobulinemia, x-linked agammaglobulinemia, xla